Free Trial

SIGA Technologies (SIGA) Competitors

+0.03 (+0.35%)
(As of 07/12/2024 ET)


Should you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Emergent BioSolutions (EBS), Flexion Therapeutics (FLXN), Organogenesis (ORGO), 89bio (ETNB), Amneal Pharmaceuticals (AMRX), Deciphera Pharmaceuticals (DCPH), Janux Therapeutics (JANX), Maravai LifeSciences (MRVI), Protagonist Therapeutics (PTGX), and Edgewise Therapeutics (EWTX). These companies are all part of the "medical" sector.

SIGA Technologies vs.

SIGA Technologies (NASDAQ:SIGA) and Emergent BioSolutions (NYSE:EBS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

SIGA Technologies has a net margin of 50.48% compared to Emergent BioSolutions' net margin of -47.68%. SIGA Technologies' return on equity of 51.97% beat Emergent BioSolutions' return on equity.

Company Net Margins Return on Equity Return on Assets
SIGA Technologies50.48% 51.97% 39.51%
Emergent BioSolutions -47.68%-18.53%-7.14%

SIGA Technologies has higher earnings, but lower revenue than Emergent BioSolutions. Emergent BioSolutions is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SIGA Technologies$139.92M4.43$68.07M$1.107.93
Emergent BioSolutions$1.05B0.53-$760.50M-$11.01-0.97

55.4% of SIGA Technologies shares are held by institutional investors. Comparatively, 78.4% of Emergent BioSolutions shares are held by institutional investors. 1.5% of SIGA Technologies shares are held by insiders. Comparatively, 1.2% of Emergent BioSolutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Emergent BioSolutions received 409 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 66.56% of users gave Emergent BioSolutions an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.

SIGA TechnologiesOutperform Votes
Underperform Votes
Emergent BioSolutionsOutperform Votes
Underperform Votes

SIGA Technologies has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Emergent BioSolutions has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500.

Emergent BioSolutions has a consensus price target of $8.00, suggesting a potential downside of 24.88%. Given Emergent BioSolutions' higher probable upside, analysts clearly believe Emergent BioSolutions is more favorable than SIGA Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SIGA Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
Emergent BioSolutions
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)

In the previous week, Emergent BioSolutions had 1 more articles in the media than SIGA Technologies. MarketBeat recorded 5 mentions for Emergent BioSolutions and 4 mentions for SIGA Technologies. SIGA Technologies' average media sentiment score of 0.81 beat Emergent BioSolutions' score of 0.20 indicating that SIGA Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SIGA Technologies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Emergent BioSolutions
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)


SIGA Technologies beats Emergent BioSolutions on 9 of the 17 factors compared between the two stocks.

Get SIGA Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

MetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$620.17M$7.26B$5.33B$8.70B
Dividend YieldN/A2.75%2.84%4.05%
P/E Ratio7.9311.63117.5915.43
Price / Sales4.43273.712,170.2379.17
Price / Cash9.0033.3335.5032.70
Price / Book3.155.844.914.46
Net Income$68.07M$146.83M$110.93M$215.59M
7 Day Performance12.66%10.49%6.14%5.35%
1 Month Performance15.50%4.69%4.27%3.36%
1 Year Performance74.05%-0.55%5.60%0.94%

SIGA Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
Emergent BioSolutions
3.1114 of 5 stars
3.11 / 5 stars
+46.3%$518.25M$1.05B-0.971,600Short Interest ↓
News Coverage
Flexion Therapeutics
0 of 5 stars
0.00 / 5 stars
N/AN/A$458.93M$85.55M-4.54257Analyst Forecast
4.5137 of 5 stars
4.51 / 5 stars
-20.7%$391.09M$433.14M72.77862News Coverage
Positive News
1.0769 of 5 stars
1.08 / 5 stars
-52.7%$862.83MN/A-4.3770News Coverage
Amneal Pharmaceuticals
1.135 of 5 stars
1.14 / 5 stars
+136.1%$2.24B$2.39B-12.847,700Short Interest ↑
News Coverage
Deciphera Pharmaceuticals
2.7761 of 5 stars
2.78 / 5 stars
Janux Therapeutics
3.0933 of 5 stars
3.09 / 5 stars
+251.6%$2.19B$8.08M-36.2568Short Interest ↑
Maravai LifeSciences
3.7968 of 5 stars
3.80 / 5 stars
-30.4%$2.17B$288.95M-9.03650Analyst Forecast
Options Volume
News Coverage
Protagonist Therapeutics
1.9773 of 5 stars
1.98 / 5 stars
+68.8%$2.10B$60M14.80112Short Interest ↓
News Coverage
Positive News
Edgewise Therapeutics
2.4082 of 5 stars
2.41 / 5 stars
+200.1%$2.09BN/A-14.4692Analyst Forecast

Related Companies and Tools

This page (NASDAQ:SIGA) was last updated on 7/14/2024 by Staff

From Our Partners